Beleggingsadviezen
Crucell Announces Registration of Hepavax-Gene® in... 08-12-2008
DSM Biologics and Crucell Announce Commercial PER.C... 25-11-2008
Crucell Announces Third Quarter 2008 Results 11-11-2008
Crucell Doubles Production of Quinvaxem® in 2008 a... 21-10-2008
Aeras and Crucell Announce TB Vaccine Clinical Tria... 17-10-2008
Crucell Receives NIAID/NIH Contract for Development... 03-10-2008
Crucell Announces Positive Results of Phase II Clin... 02-10-2008
DSM and Crucell announce another key achievement fo... 29-09-2008
Lonza and Crucell enter into long term agreement 25-09-2008
Crucell, new contracts awarded for Quinvaxem® and ... 23-09-2008
Crucell Signs Exclusive License Agreement with Tale... 18-09-2008
Crucell to move Dukoral® and rCTB bulk production,... 26-08-2008
Crucell Announces Second Quarter 2008 Results 12-08-2008
DSM and Crucell Sign Agreement with Avid Bioservice... 25-06-2008
DSM en Crucell bereiken nieuw record met PER.C6® t... 16-06-2008
Crucell in de overgang. 31-05-2008
Crucell, Start of Phase II Clinical Study for Rabie... 13-05-2008
Crucell Announces First Quarter 2008 Results 13-05-2008
Aeras, Crucell and SATVI Announce Encouraging Preli... 09-04-2008
Crucell Announces First in Man Study with New Adeno... 03-04-2008
Crucell Announces Start of Phase II Clinical Study ... 31-03-2008
Crucell and DSM Biologics Announce Additional PER.C... 17-03-2008
DSM and Crucell Announce PER.C6® Technology Milest... 11-03-2008
Crucell Announces Fourth Quarter and Full Year 2007... 12-02-2008
Crucell Reacts to Recent CEVEC Press Release 16-01-2008
Crucell TRADING UPDATE 09-01-2008
Crucell Enters Agreement with Sanofi Pasteur for Ne... 03-01-2008
Aeras and Crucell Announce Start of a Tuberculosis ... 21-12-2007
Crucell Announces Research License Agreement with P... 17-12-2007
Crucell Presents Indian Phase I Rabies Antibody Coc... 30-11-2007
Crucell Announces Third Quarter 2007 Results 13-11-2007
Crucell Sells Stake in Pevion Biotech 12-11-2007
Crucell Announces Marketing and Distribution Deal w... 12-11-2007
MEDIMMUNE AND CRUCELL ANNOUNCE COLLABORATION TO DEV... 15-10-2007
Crucell presents Phase I results rabies antibody co... 03-10-2007
Crucell discovers human monoclonal antibodies for..... 28-09-2007
Crucell,Impact of discontinuation of Merck HIV stud... 25-09-2007
Crucell to present pre-clinical results for H5N1 Vi... 14-09-2007
Crucell announces new STAR® technology research li... 06-09-2007
Crucell Announces Second Quarter 2007 Results 14-08-2007
Crucell announces Vaccine and Protein Business Unit... 18-07-2007
DSM Biologics and Crucell Announce PER.C6® Licensi... 10-07-2007
Biotech zal ook een prooi kunnen gaan worden van KK... 03-06-2007
Crucell, AERAS and SATVI Announce Start of Tubercul... 11-05-2007
Crucell Announces First Quarter 2007 Results 09-05-2007
Cruccell contra Innoconcepts. 07-04-2007
Crucell broadens pandemic preparedness with grant a... 05-04-2007
Crucell Announces Start of Rabies Phase I Antibody ... 04-04-2007
Crucell secures important patent covering influenza... 03-04-2007
Crucell announces European protein distribution dea... 03-04-2007

Copyrights © 2000 by XEA.nl all rights reserved
Niets mag zonder toestemming van de redactie worden gekopieerd, linken naar deze pagina is wel toegestaan.